The story has been updated to include commments from Danaher's conference call.

NEW YORK (GenomeWeb News) – Danaher today reported that its sales in the first quarter increased 3 percent year over year, while sales in the Life Science and Diagnostics segment inched up 1 percent.

The company recorded companywide sales of $4.44 billion, up from $4.32 billion in the first quarter of 2012, but short of the average Wall Street estimate of $4.50 billion.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In an against-all-odds twist, a researcher studying exceeding rare FOXG1 mutations discovers her daughter has the syndrome.

An effort by Genomics Medicine Ireland is creating a database of diseases based on the genomics of people in Ireland. It now is looking into the possibility of including Scotland in its work.

In recent weeks, the direct-to-consumer genetics firm has rolled out a health hub where customers can share information concerning 18 common health conditions.

In PLOS this week, new genes associated with prostate cancer risk, genetic patterns in M. bovis, and more.